Shopping Cart
- Remove All
- Your shopping cart is currently empty
Alrefimotide, an immunogenic peptide derived from hTERT, possesses the sequence ALFSVLNYERARRPGLLGASVLGLDDIHRA and has applications in cancer immunotherapy research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Alrefimotide, an immunogenic peptide derived from hTERT, possesses the sequence ALFSVLNYERARRPGLLGASVLGLDDIHRA and has applications in cancer immunotherapy research [1]. |
Alias | hTERT (660–689) |
Molecular Weight | 3280.74 |
Formula | C146H239N45O41 |
Cas No. | 1331848-79-3 |
Sequence | Ala-Leu-Phe-Ser-Val-Leu-Asn-Tyr-Glu-Arg-Ala-Arg-Arg-Pro-Gly-Leu-Leu-Gly-Ala-Ser-Val-Leu-Gly-Leu-Asp-Asp-Ile-His-Arg-Ala |
Sequence Short | ALFSVLNYERARRPGLLGASVLGLDDIHRA |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.